Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
20/09/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/09/202215:05GlobeNewswire Inc.Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk SubjectsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/09/202205:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/09/202216:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/08/202214:09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/08/202216:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Results of Annual Meeting of StockholdersNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/202215:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/202215:02GlobeNewswire Inc.Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/08/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/07/202207:15TipRanksDawson James Sticks to Its Hold Rating for Adamis Pharma (ADMP)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/202207:00GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals’ Stockholders Vote FOR Critical Proposals at Upcoming Annual MeetingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/07/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Issues Letter to StockholdersNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/07/202215:38Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/07/202215:26Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/06/202215:34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/05/202215:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202215:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202215:05GlobeNewswire Inc.Adamis Appoints Vickie Reed to Board of DirectorsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/05/202216:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and GrowthNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/05/202215:35GlobeNewswire Inc.Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/05/202216:56GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/05/202216:07Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202216:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202215:49GlobeNewswire Inc.Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/03/202215:14GlobeNewswire Inc.US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster ModelNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/03/202215:05GlobeNewswire Inc.Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing DefectNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/03/202206:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Retirement of Richard C. Williams, Chairman of the BoardNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP